Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase 1 Study of 5-Fluorouracil in Combination With Abemaciclib in Metastatic, Refractory CRC

NCT06654037 is registered in ClinicalTrials.gov with National Cancer Institute (NCI) as lead sponsor.

NCT NCT06654037
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06654037 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase 1 Study of 5-Fluorouracil in Combination With Abemaciclib in Metastatic, Refractory CRC
Lead sponsor
National Cancer Institute (NCI)
Phase
Phase 1
Overall status
Recruiting
Start date
April 18, 2025
Completion date
April 1, 2027
Enrollment
39 (estimated)
Sites
8

Conditions

As the registry lists them; a condition with its own page is linked.

metastatic microsatellite stable colorectal carcinoma, refractory microsatellite stable colorectal carcinoma, stage iv colorectal cancer ajcc v8